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Purpose
Safety of dietary supplements has been an area of con-
cern for regulators, the health care community and con-
sumers. The ability of the FDA to assess validity of
these concerns has been hampered by small numbers of
voluntary AE reports. In 2006 Congress mandated all
serious adverse events be reported by dietary supple-
ment manufacturers. We present the first systematic
analysis of the initial two years of reports.
Methods
We obtained AER’s for 2008 and 2009 from the FDA
( n = 2 , 2 8 8 ) .D a t aw e r ea b s t r a c t e db yas i n g l er e v i e w e r ,
confirmed by at least one other, entered into a standard
excel sheet, and analyzed using SPSS. Non-parametric
tests of significance were also applied.
Results
In preliminary results, manufacturers accounted for
57.8% of all reports, consumers 29.6% and health care
professionals 9.7%. 61.8% of subjects were female. The
most commonly reported dietary ingredients were com-
bination products (33.5%), vitamin/mineral (19%), and
plant or isolated plant constituent (15.8%). 297 reports
included multiple products. Fifty-five percent of reports
included the label or label information. The most com-
mon adverse outcome was hospitalization (750, 32.8%).
Thirty-one deaths were reported (1.4% total reports), 56
episodes of disability (2.4%), 233 life-threatening compli-
cations (10.2%), and 943 other serious adverse events
(41.2%). A detailed assessment of deaths, hospitalizations
and life threatening complications will be presented. No
single product type or ingredient was significantly asso-
ciated with death. Attempts to apply the WHO-UMC
causality assessment system yielded limited results and
would be improved with the collection of more suffi-
cient data. A cluster of serious adverse events involving
a single exercise enhancement product was identified.
Conclusion
Mandated reporting has increased manufacturer reports
but missing data limits analysis. Preliminary results do
not suggest a wide spread problem with dietary supple-
ment safety. This analysis did identify a cluster of cases
representing a potential public health concern. Direc-
tions for future research will be discussed.
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